Pediatric Inherited Diseases Research Center, Genetics and Molecular Biology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Cell Mol Neurobiol. 2013 May;33(4):569-74. doi: 10.1007/s10571-013-9923-x. Epub 2013 Mar 20.
Somatic cells do not have telomerase activity but immortalized cell lines and more than 85 % of the cancer cells show telomerase activation to prevent the telomere from progressive shortening. The activation of this enzyme has been found in a variety of human tumors and tumor-derived cell lines, but only few studies on telomerase activity in human brain tumors have been reported. Here, we evaluated telomerase activity in different grades of human astrocytoma and meningioma brain tumors. In this study, assay for telomerase activity performed on 50 eligible cases consisted of 26 meningioma, 24 astrocytoma according to the standard protocols. In the brain tissues, telomerase activity was positive in 39 (65 %) of 50 patients. One sample t test showed that the telomerase activity in meningioma and astrocytoma tumors was significantly positive entirely (P < 0.001). Also, grade I of meningioma and low grades of astrocytoma (grades I and II) significantly showed telomerase activity. According to our results, we suggest that activation of telomerase is an event that starts mostly at low grades of brain including meningioma and astrocytoma tumors.
体细胞没有端粒酶活性,但永生化细胞系和超过 85%的癌细胞显示端粒酶激活,以防止端粒进行性缩短。这种酶的激活已在多种人类肿瘤和肿瘤衍生的细胞系中发现,但关于人类脑肿瘤中端粒酶活性的研究很少。在这里,我们评估了不同分级的人脑星形细胞瘤和脑膜瘤脑肿瘤中端粒酶的活性。在这项研究中,根据标准方案,对 50 例合格病例进行了端粒酶活性检测,其中包括 26 例脑膜瘤和 24 例星形细胞瘤。在脑组织中,50 例患者中有 39 例(65%)端粒酶活性阳性。单样本 t 检验显示脑膜瘤和星形细胞瘤肿瘤的端粒酶活性均显著阳性(P<0.001)。此外,I 级脑膜瘤和低级别星形细胞瘤(I 级和 II 级)显著显示端粒酶活性。根据我们的结果,我们认为端粒酶的激活是一个事件,主要发生在包括脑膜瘤和星形细胞瘤在内的脑的低级别。